News

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
The global insulin delivery pen market is estimated to record a CAGR of 8.1% from 2024 to 2034. This is likely to take the ...
Insulin efsitora alfa (investigational once-weekly basal insulin): In another ADA-sponsored symposium, Lilly will share results from the QWINT-1, QWINT-3 and QWINT-4 Phase 3 trials, which evaluated ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has deferred its decision on ...
Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...
Learn how to give yourself an insulin shot for diabetes using a syringe. Follow safe insulin injection steps to manage blood ...
and outcomes Proper injection technique procedures for insulin pens and syringes, from insulin storage to needle disposal Lipodystrophy risk reduction, with a focus on lipohypertrophy Structured ...
Insulin delivery pens are injection devices that allow you to deliver preloaded insulin into your subcutaneous tissue, the innermost layer of skin in your body. Taking insulin pens is more ...
This move is a milestone, he noted, as for the first time insulin is being produced as pens inside Egypt, after it was previously produced only in the form of injections. This achievement reflects ...
Zacks Investment Research on MSN6mon
MDT Stock Gains From FDA Approval for Its InPen App
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...
The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections. The ...